Article
Exclusive: U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
Rating:
0.0
Views:
57
Likes:
1
Library:
1
U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory in North America as early as May last year, according to the report obtained by Reuters via a Freedom of Information Act request.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value